Dragana Slavkovic-Lukic

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Venues

Nature nanotechnology

Signal transduction and targeted therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Dragana Slavkovic-Lukic, Luca Gattinoni
Nanowires engineer naive T cells for immunotherapy. Nature nanotechnology 19 (8) (2024)
Dragana Slavkovic-Lukic, Luca Gattinoni
Nanowires engineer naive T cells for immunotherapy. Nature nanotechnology (2024)
Roland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni, Jeremy G Baldwin, Nisha Rana, Peng Li, Ping Chen, Timea Vadász, Rosanne Spolski, Christoph Heuser, Dragana Slavkovic-Lukic, Pedro Noronha, Giuseppe Damiano, Laura Raccosta, Daniela Maggioni, Sree Pullugula, Jian-Xin Lin, Jangsuk Oh, Patrick Grandinetti, Mario Lecce, Leo Hesse, Emilia Kocks, Azucena Martín-Santos, Claudia Gebhard, William G Telford, Yun Ji, Nicholas P Restifo, Vincenzo Russo, Michael Rehli, Wolfgang Herr, Warren J Leonard, Luca Gattinoni
LIM-domain-only 4 (LMO4) enhances CD8 + T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling. Signal transduction and targeted therapy 9 (1) (2024)
Roland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni, Jeremy G Baldwin, Nisha Rana, Peng Li, Ping Chen, Timea Vadász, Rosanne Spolski, Christoph Heuser, Dragana Slavkovic-Lukic, Pedro Noronha, Giuseppe Damiano, Laura Raccosta, Daniela Maggioni, Sree Pullugula, Jian-Xin Lin, Jangsuk Oh, Patrick Grandinetti, Mario Lecce, Leo Hesse, Emilia Kocks, Azucena Martín-Santos, Claudia Gebhard, William G Telford, Yun Ji, Nicholas P Restifo, Vincenzo Russo, Michael Rehli, Wolfgang Herr, Warren J Leonard, Luca Gattinoni
LIM-domain-only 4 (LMO4) enhances CD8 + T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling. Signal transduction and targeted therapy 9 (1) (2024)
Roland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni, Jeremy G Baldwin, Nisha Rana, Peng Li, Ping Chen, Timea Vadász, Rosanne Spolski, Christoph Heuser, Dragana Slavkovic-Lukic, Pedro Noronha, Giuseppe Damiano, Laura Raccosta, Daniela Maggioni, Sree Pullugula, Jian-Xin Lin, Jangsuk Oh, Patrick Grandinetti, Mario Lecce, Leo Hesse, Emilia Kocks, Azucena Martín-Santos, Claudia Gebhard, William G Telford, Yun Ji, Nicholas P Restifo, Vincenzo Russo, Michael Rehli, Wolfgang Herr, Warren J Leonard, Luca Gattinoni
LIM-domain-only 4 (LMO4) enhances CD8 + T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling. Signal transduction and targeted therapy 9 (1) (2024)
Dragana Slavkovic-Lukic, Luca Gattinoni
Nanowires engineer naive T cells for immunotherapy. Nature nanotechnology 19 (8) (2024)

Dragana Slavkovic-Lukic.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Dragana Slavkovic-Lukic